Peptides in Topical Formulations: Penetration and Stability

Two separate problems

A peptide in a cream has to survive in the jar and then reach a useful place in the skin. These are different challenges, and a product can fail at either. This page covers the science only; it is not product advice. For the broader delivery picture see topical and transdermal delivery claims.

Problem 1: getting through the skin barrier

The skin's outer layer (the stratum corneum) is a fatty barrier. A review of cosmeceutical peptides listed the reasons absorption may be poor: low fat-solubility, high molecular weight and binding to other ingredients in the product. [1]

Examples from the literature:

• KTTKS (the chain behind Matrixyl): one lab study says it minimally crosses skin because it is water-loving, and that is why its palmitoyl version is used in cosmetics. [2]
• Acetyl hexapeptide-8 (Argireline): a 2025 review found limited permeability through the stratum corneum and uncertainty about whether it reaches nerve-muscle junctions. [3]
• GHK-Cu and Pal-GHK: a 2025 review said published information on skin permeability and effectiveness is insufficient. [4]
• Palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 (in Matrixyl 3000): in a small 2026 study of three volunteers, surface imaging detected both in every sampled layer of the outer skin, with signal dropping off quickly with depth. The authors read this as the peptides sitting on the outer surfaces of cells rather than inside them. [5] This is three people and a measurement of location, not evidence of a skin benefit.

Problem 2: staying intact

Peptides can break apart. A review of topical delivery discusses the physical and chemical routes by which peptides degrade and why that complicates formulating them. [6]

• Skin itself contains enzymes. A lab method study notes that widespread dermal proteases may affect peptide stability and efficacy. [7] In rat skin samples, KTTKS was very susceptible to cleavage by aminopeptidases. [8] That is preclinical.
• Chemistry matters. In a preformulation study, GHK-Cu degraded under basic and oxidizing stress, yet was stable in water and mildly acidic to neutral buffers for at least two weeks at 60 degrees C in that test. [9] Results like these describe one peptide under lab conditions, not every product.
• Other ingredients matter. A mass-spectrometry study found Argireline and an oxidized form of it in several cosmetics, and raised the question of how other ingredients affect product stability. [10]

Formulation strategies being studied

Reviews describe oil-and-water emulsions, liposomes, other nanocarriers, metal complexation, chemical modification and microneedles as ways to improve peptide delivery. [6] [4] One lab study put palmitoyl-KTTKS into liposomes and reported more collagen production than the free peptide in its test system. [11]

Two cautions apply. First, a successful lab test is preclinical. Second, "liposomal," "nano" or "encapsulated" on a label is a marketing claim unless a study of that exact product shows more benefit. See encapsulation, liposomes and nanoparticles.

What this means when reading a label

• A peptide that is hard to deliver may still be listed prominently; the label does not show how much reaches the skin.
• How a product should be stored and used is set by its maker and is not covered here.
• Better formulation science is not the same as a proven result. See ingredient evidence versus finished-product evidence and stability and storage science.